AbbVie
ABBV
#35
Rank
$241.46 B
Marketcap
$136.86
Share price
-0.01%
Change (1 day)
-6.60%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of December 2022 : $63.27 B

According to AbbVie's latest financial reports the company's total debt is $63.27 B. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2012 to 2022)

Total debt by year

Year Total debt Change
2022-12-31$63.27 B-17.49%
2021-12-31$76.68 B-10.89%
2020-12-31$86.05 B28.97%
2019-12-31$66.72 B65.54%
2018-12-31$40.31 B7.87%
2017-12-31$37.36 B1.43%
2016-12-31$36.84 B16.33%
2015-12-31$31.67 B110.99%
2014-12-31$15.01 B1.96%
2013-12-31$14.72 B-6.06%
2012-12-31$15.67 B

Total debt for similar companies or competitors

Company Total debt differencediff. Country
$34.87 B-44.89%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.88 B-70.15%๐Ÿ‡บ๐Ÿ‡ธ USA
$61.59 B-2.65%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.60 B-89.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.23 B-60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$39.37 B-37.77%๐Ÿ‡บ๐Ÿ‡ธ USA
$31.50 B-50.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
$25.89 B-59.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
$0.25 B-99.59%๐Ÿ‡บ๐Ÿ‡ธ USA